| Serial Number | 97691779 |
| Word Mark | GENLINK3D |
| Filing Date | Friday, November 25, 2022 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, June 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Downloadable software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Downloadable software for visualisation, analysis, and manipulation of biological molecules in the field of genomics; Downloadable software for visualisation, analysis, and manipulation of biological molecules; Downloadable software for modelling and prediction of biological interactions; Downloadable software for genome sequencing; Scientific research apparatus and instruments for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Electronic database in the field of genomics recorded on computer media; Downloadable educational publications, namely, printable workbooks, booklets, reviews, scientific journals, and articles in the field of genomics; Downloadable electronic publications in the nature of scientific journals, articles, and reviews in the field of drug discovery; Downloadable electronic publications in the nature of scientific journals, articles, and reviews in the field of medical diagnosis; Downloadable electronic publications in the nature of scientific journals, articles, and reviews in the field of biomarker discovery; Downloadable electronic publications in the nature of scientific journals, articles, and reviews in the field of genomics; Downloadable electronic publications in the nature of scientific journals, articles, and reviews in the field of bioinformatics |
| Pseudo Mark | GEN LINK THREE D; GENLINKED |
| Goods and Services | Financial data analysis; Financial data analysis in the field of drug discovery; Financial data analysis in the field of medical diagnosis; Financial data analysis in the field of biomarker discovery; Financial data analysis in the field of genomics; Financial data analysis in the field of bioinformatics |
| Goods and Services | Business data analysis in the field of drug discovery; Business data analysis in the field of medical diagnosis; Business data analysis in the field of biomarker discovery; Business data analysis in the field of genomics; Business data analysis in the field of bioinformatics; Data processing in the field of drug discovery; Data processing in the field of medical diagnosis; Data processing in the field of biomarker discovery; Data processing in the field of genomics; Data processing in the field of bioinformatics; Database management; Database management and reporting services; Business information services in the fields of medical diagnosis, biomarker discovery, genomics, and bioinformatics; Business consulting services in the fields of medical diagnosis, biomarker discovery, genomics, and bioinformatics; Business consulting services in the field of drug discovery; Business consulting services in the field of biomarker discovery; Market intelligence services in the fields of medical diagnosis, biomarker discovery, genomics, and bioinformatics; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Compilation of data for use in scientific research; Information, advisory and consultancy services in relation to all of the aforesaid |
| Goods and Services | Software as a service (SAAS) services for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Software as a service (SAAS) services featuring software for research and development of drugs in the field of genomics; Software as a service (SAAS) services featuring software for diagnosis of genetic diseases; Software as a service (SAAS) services featuring software for development of biomarkers for medical treatment; Software as a service (SAAS) services featuring software for collection, analysis and interpretation of biological data; Software as a service (SaaS) services featuring software for visualisation, analysis, and manipulation of biological molecules; Software as a service (SaaS) services featuring software for modelling and prediction of biological interactions; Software as a service (SaaS) services featuring software for genome sequencing; Software as a service (SAAS) services featuring software for data analysis, data processing and database management in the field of genomics; Software as a service (SAAS) services featuring software for research and development of artificial intelligence and machine learning the field of genomics; Platform as a service (PAAS) featuring computer software platforms for data analysis, data processing and database management in the field of genomics; Platform as a service (PAAS) featuring computer software platforms for research and development of drugs in the field of genomics; Platform as a service (PAAS) featuring computer software platforms for diagnosis of genetic diseases; Platform as a service (PAAS) featuring computer software platforms for development of biomarkers for medical treatment; Platform as a service (PAAS) featuring computer software platforms for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Platform as a service (PAAS) featuring computer software platforms for collection, analysis and interpretation of biological data; Platform as a service (PaaS) featuring computer software platforms for visualisation, analysis, and manipulation of biological molecules; Platform as a service (PaaS) featuring computer software platforms for modelling and prediction of biological interactions; Platform as a service (PaaS) featuring computer software platforms for genome sequencing; Platform as a service (PaaS) featuring computer software platforms for performing data analysis, data processing, and database management in the fields of medical diagnosis, biomarker discovery, genomics, and bioinformatics; Platform as a service (PaaS) featuring computer software platforms in the field of artificial intelligence and machine learning; Design and development of software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Design and development of software in the field of drug discovery; Design and development of software in the field of medical diagnosis; Design and development of software in the field of biomarker discovery; Design and development of software in the field of genomics; Design and development of software in the field of bioinformatics; Design and development of software for visualisation, analysis, and manipulation of biological molecules; Design and development of software for modelling and prediction of biological interactions; Design and development of software for genome sequencing; Design and development of software for performing data analysis in the fields of medical diagnosis, biomarker discovery, genomics, and bioinformatics; Design and development of software in the field of artificial intelligence and machine learning; Scientific research services for others in the field of genomics; Scientific research services for others in the field of drug discovery; Scientific research services for others in the field of medical diagnosis; Scientific research services for others in the field of biomarker discovery; Scientific research services for others in the field of genomics; Scientific research services for others in the field of bioinformatics; Scientific research consulting services in the field of drug discovery; Scientific research consulting services in the field of medical diagnosis; Scientific research consulting services in the field of biomarker discovery; Scientific research consulting services in the field of genomics; Scientific research consulting services in the field of bioinformatics; Scientific and technological services, namely, profiling three-dimensional genome folding at high resolution for all genes and their enhancers, in the field of genomics; Scientific and technological services, namely, scientific testing in the field of drug discovery; Scientific and technological services, namely, scientific testing in the field of medical diagnosis; Scientific and technological services, namely, scientific testing in the field of biomarker discovery; Scientific and technological services, namely, scientific testing in the field of genomics; Scientific and technological services, namely, scientific testing in the field of bioinformatics; Computer services for the analysis of data for scientific purposes; Providing temporary use of on-line non-downloadable software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Information, advisory and consultancy services in relation to all of the aforesaid |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, December 18, 2022 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, December 18, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 13, 2024 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, December 18, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ENHANC3D GENOMICS LTD |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Cambridge CB223AT GB |
| Event Date | Event Description |
| Tuesday, November 29, 2022 | NEW APPLICATION ENTERED |
| Wednesday, September 6, 2023 | ASSIGNED TO EXAMINER |
| Sunday, December 18, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, September 18, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, September 18, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, September 18, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, December 13, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, March 13, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 13, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, March 13, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, December 13, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Thursday, April 18, 2024 | ASSIGNED TO EXAMINER |
| Monday, June 3, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 3, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, June 3, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 3, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, September 3, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |